Livius Penter, MD1,2,3,4, Yang Liu, PhD5*, Lin Yang, MS5*, Len Taing, MS5*, Aashna Jhaveri, MS5*, Jackson Southard, BS6*, Manishkumar Patel, MSc7*, Jacquelyn Wolff, BS8*, Nicole Cullen, BS8*, Kathleen Pfaff, PhD8*, Nicoletta Cieri, MD, PhD3,4,9*, Giacomo Oliveira, PhD9*, Seunghee Kim-Schulze, PhD7*, Srinika Ranasinghe, PhD8*, Rebecca Leonard, BA9*, Taylor Robertson, BS9*, Helen Chen, MD10*, Magdalena Thurin, PhD10*, Shuqiang Li, PhD6,9*, Scott J. Rodig, MD, PhD11, Carrie Cibulskis, BSc4*, Stacey Gabriel, PhD4*, Jerome Ritz, MD, PhD9, Howard Streicher, MD10*, Donna S. Neuberg, ScD5, Stephen Hodi, MD9*, Sacha Gnjatic, PhD7*, Kenneth J Livak, PhD6,9*, Jennifer Altreuter, MD5*, Franziska Michor, Ph.D.5*, Robert J Soiffer, MD12, Jacqueline S. Garcia, MD9 and Catherine J. Wu, MD9
1Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
2Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
3Harvard Medical School, Boston, MA
4Broad Institute of MIT and Harvard, Cambridge, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
7Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY
8Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
10Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD
11Department of Pathology, Brigham and Women's Hospital, Boston, MA
12Division of Stem Cell Transplant and Cellular Therapies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA